G1 Therapeutics, Inc. (GTHX) Weighted Average Number of Shares Outstanding, Basic 2021 - 2024

Historical data

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
G1 Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from 2021 to 2024.
  • G1 Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending March 31, 2024 was 52.2 M shares, a 1.01% increase year-over-year.
  • G1 Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 51.7 M shares, a 18.6% increase from 2022.
  • G1 Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 43.6 M shares, a 4.01% increase from 2021.
  • G1 Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 41.9 M shares, a 10.7% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 52.2 M +524 K +1.01% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-01
Q4 2023 51.7 M +5.45 M +11.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 51.8 M +8.98 M +21% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-01
Q2 2023 51.7 M +8.96 M +21% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-02
Q1 2023 51.6 M +8.96 M +21% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-01
Q4 2022 46.3 M +3.74 M +8.78% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-01
Q3 2022 42.8 M +416 K +0.98% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-01
Q2 2022 42.7 M +588 K +1.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 42.7 M +1.99 M +4.88% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q4 2021 42.5 M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-01
Q3 2021 42.4 M Jul 1, 2021 Sep 30, 2021 10-K 2023-03-01
Q2 2021 42.1 M Apr 1, 2021 Jun 30, 2021 10-K 2023-03-01
Q1 2021 40.7 M Jan 1, 2021 Mar 31, 2021 10-K 2023-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.